
Advertise on podcast: The Pharm So Hard Emergency Medicine & Hospital Pharmacy Podcast
Rating
4.8from
This podcast has
132 episodes
Language
EnglishExplicit
No
Date created
2019/09/10
Latest episode
2026/06/23
Average duration
32 min.
Release period
49 days
Description
The Pharm So Hard Podcast is a show focused primarily on emergency medicine and hospital pharmacy related topics. Episodes range from 5-30 minutes depending on the topic and guest speakers. The goal is to disseminate information in bite-sized episodes from experts in the field of acute care and hospital pharmacy sub-specialties.
Unlock The Pharm So Hard Emergency Medicine & Hospital Pharmacy Podcast podcast Email contact info,
Listeners & Audience details
Email contact information
Direct podcast contact details

Listeners
Audience numbers & engagement insights

Audience details
Podcast Insights

Social media
Check The Pharm So Hard Emergency Medicine & Hospital Pharmacy Podcast social media presence
Podcast episodes
Check latest episodes from The Pharm So Hard Emergency Medicine & Hospital Pharmacy Podcast podcast
Episode 131. ED Boarding and the Emergency Medicine Pharmacist
2026/06/23
In this episode of the Pharm So Hard Podcast, host Jimmy Pruitt, PharmD, BCPS, BCCCP, BCEMP, is joined by Brian Gilbert, PharmD, MBA, FCCM, FNCS, FCCP, FASHP, FKCHP, Heather Blue, PharmD, BCPS, FMSHP, BCEMP, Alyssa Robertson, PharmD, BCPS, BCCCP, BCEMP, and David Zimmerman, PharmD, BCCCP, BCEMP, FASHP, FCCP, to discuss one of the most pressing operational challenges facing emergency medicine pharmacists today: ED boarding.
Drawing from their recent publication in the Journal of the American College of Clinical Pharmacy, the panel explores the growing tension between ensuring high-quality pharmacy care for boarded patients and protecting the core responsibilities of the emergency medicine pharmacist. As admitted patients remain in the emergency department for longer periods, many institutions have unintentionally shifted inpatient pharmacy responsibilities onto ED pharmacists without clearly defining ownership, creating challenges for patient safety, workflow efficiency, and pharmacist role sustainability.
The discussion examines what emergency medicine pharmacists should own, what responsibilities belong to inpatient pharmacy teams, and how health systems can build workflows that provide appropriate care for boarded patients without compromising critical ED services such as resuscitations, time-sensitive medication decision-making, protocol development, and bedside emergency care. The panel also shares practical strategies for pharmacy leaders, directors, and frontline clinicians to address role drift, improve accountability, and create sustainable staffing models that support both boarded patients and emergency department operations. Whether you practice in an academic medical center, community hospital, or resource-limited setting, this episode provides actionable insights for defining pharmacy ownership and preserving the highest-impact contributions of emergency medicine pharmacists.
★ Support this podcast ★
Episode 130. Single-Dose Aminoglycosides for Resistant UTIs
2026/04/20
In Episode 130 of The Pharm So Hard Podcast, host Jimmy Pruitt, PharmD, BCPS, BCCCP, BCEMP, is joined by Hunter Rondeau, PharmD, BCIDP, AAHIVP, antimicrobial stewardship coordinator at SSM Health, to explore the growing role of single-dose aminoglycosides for urinary tract infections with limited oral treatment options.
Hunter shares how this strategy gained traction through emergency department culture-callback programs and antimicrobial stewardship efforts, highlighting real-world scenarios where a single IV dose can prevent unnecessary admissions, PICC placement, and prolonged antibiotic exposure. The discussion dives into the evolving resistance landscape, the rise of ESBL and CRE organisms, and the clinical decision-making needed to identify the right patients for this approach.
Jimmy and Hunter also review key evidence, including systematic reviews, IDSA guidance, and emerging emergency medicine data that support the safety and effectiveness of single-dose aminoglycosides. From patient selection and workflow implementation to provider education and follow-up, this episode offers practical insights for pharmacists looking to expand their impact in the ED and beyond.
If you’re interested in antimicrobial stewardship, emergency medicine pharmacy, and innovative ways to manage resistant UTIs while keeping patients out of the hospital, this episode is packed with pearls you can apply in practice.
★ Support this podcast ★
Episode 129. JACP Spotlight: Reducing Prescription Abandonment With ED Pharmacy Kiosks
2026/02/10
In Episode 129 of The Pharm So Hard Podcast, host Jimmy Pruitt, PharmD, BCPS, BCCCP, BCEMP, is joined by Oscar Santalo, PharmD, MBA, MHA, BCPS, to discuss his recently published study in the Journal of Acute Care Pharmacotherapy (JACP) examining prescription abandonment after emergency department discharge. Jimmy and Oscar walk through the motivation behind the research and explore how automated pharmacy kiosks may serve as a practical solution to improve medication access at the point of discharge. The conversation focuses on why prescription abandonment remains a persistent challenge in emergency care and how pharmacy-led innovations can help bridge gaps during transitions from the ED to home. This episode also takes a broader look at the role of clinical pharmacy in emergency medicine, highlighting how system-level approaches can support adherence, continuity of care, and better patient experiences. If you’re interested in how evidence published in JACP can inform real-world practice, this episode offers thoughtful insight from the study’s author himself.
★ Support this podcast ★
Episode 128. Don't Ask Why Give it in the Thigh!! IM Epinephrine in Anaphylaxis
2026/01/28
In Episode 128 of The Pharm So Hard Podcast, host Jimmy Pruitt, PharmD, BCPS, BCCCP, BCEMP, takes on one of the most common—and most consequential—errors in emergency care: how we give IM epinephrine for anaphylaxis. Spoiler alert: if you’re giving it in the arm, you may be giving your patient little more than saline. Using real EMS-to-ED scenarios and landmark pharmacokinetic data, Jimmy breaks down why IM epinephrine in the deltoid fails, how thigh administration delivers up to 10-fold higher plasma concentrations, and why many adults are being significantly underdosed with the standard 0.3 mg approach. This episode dives into absorption physiology, weight-based dosing, needle length, and the dangerous downstream consequences that occur when inadequate IM therapy pushes teams toward risky IV epinephrine boluses. If you manage anaphylaxis in the ED, ICU, or prehospital setting, this episode will fundamentally change how you think about epinephrine. The takeaway is simple—and non-negotiable: don’t try to outsmart physiology. Don’t ask why. Give it in the thigh.
★ Support this podcast ★
Episode 127. RSI Trial: Ketamine vs Etomidate
2026/01/15
In Episode 127 of The Pharm So Hard Podcast, host Jimmy Pruitt, PharmD, BCPS, BCCCP, BCEMP, breaks down the long-awaited RSI Trial comparing ketamine versus etomidate for rapid sequence intubation in critically ill patients. Challenging more than two decades of dogma, Jimmy explores why ketamine was associated with more early cardiovascular collapse—including higher rates of vasopressor escalation and significant blood pressure drops—despite its reputation as the “safer” agent in shock. Using real-world scenarios from the ED and ICU, this episode unpacks the concept of the ketamine hemodynamic paradox, catecholamine depletion, dosing considerations, and how these findings should change your airway preparation strategy. If you care about making intubations as boring—and as safe—as possible, this is a must-listen.
★ Support this podcast ★
Episode 126. Part 2 – Loop There It Is! Navigating Diuretics, Resistance, and Heart Failure Therapies
2025/10/10
Picking up right where Part 1 left off, this episode zeroes in on the practical, high-stakes side of inpatient heart failure management. Dr. Cait Kulig returns to unpack key adverse effects of diuresis, strategies to overcome diuretic resistance, and how to approach add-ons, IV vasoactive agents, and inotropes.
Jimmy and Cait also dive into the impact of acute decompensated heart failure on pharmacokinetics, diuretic selection, and guideline-directed therapy across HFrEF and HFpEF—including tips for transitioning to ARNIs and remembering what really matters during inpatient optimization.
Whether you're adjusting diuretics or making big-picture decisions, this episode will help you level up your heart failure confidence.
★ Support this podcast ★
Episode 125. Part 1 – Loop There It Is! Mastering the Foundations of Heart Failure
2025/10/10
In Part 1 of this two-part masterclass on acute heart failure, host Jimmy Pruitt, PharmD, BCPS, BCCCP, BCEMP, teams up with Cait E. Kulig, PharmD, HF-Cert, clinical cardiology expert and creator of CAR Rx Explain, to unpack the fundamentals of heart failure in a way that finally clicks.
From defining heart failure and understanding ejection fraction to breaking down volume status and the Forrester plot, this episode delivers clear, memorable teaching pearls for any pharmacist working with cardiac patients. Learn when to hold GDMT, how to think through diuretic strategies, and what questions you should be asking your patients on admission. This is heart failure demystified—through the lens of real-world clinical decision-making.
💡 Up next in Part 2: We pick up with the adverse reactions of diuresis, dive into overcoming diuretic resistance, and discuss IV vasoactives, GDMT classes, and more.
★ Support this podcast ★
Episode 124. Minor Hemorrhages, Major Questions: To Reverse or Not to Reverse in Minor TICH
2025/05/13
In Episode 124 of The Pharm So Hard Podcast, host Jimmy Pruitt, PharmD, BCPS, BCCCP, BCEMP, explores the ongoing debate around anticoagulation reversal in patients with minor traumatic intracranial hemorrhage (TICH). Highlighting a recent multicenter study, Jimmy breaks down the data, challenges current guideline-driven practices, and raises critical questions about risk, patient selection, and clinical judgment. Tune in for a nuanced discussion that could reshape how we approach minor TICH in the emergency department.
★ Support this podcast ★
Episode 123. Unveiling SEMP: A New Era in Emergency Medicine Pharmacy
2025/04/04
In this episode of The Pharm So Hard Podcast, host Jimmy Pruitt, PharmD, BCPS, BCCCP, BCEMP, introduces the Society of Emergency Medicine Pharmacists (SEMP), a newly established organization dedicated to advancing the practice of emergency medicine pharmacy. Jimmy discusses SEMP's mission to optimize pharmacotherapeutic care in emergency departments through practice improvement, education, advocacy, research, and international collaboration. He highlights the importance of creating a unified global community for emergency medicine pharmacists and explores how SEMP aims to provide tailored support and resources for practitioners in this dynamic field. Tune in to learn how SEMP plans to shape the future of emergency medicine pharmacy and how you can get involved.
★ Support this podcast ★
Episode 122. SGLT2 Inhibitors in the ICU - Are We Missing an Opportunity?
2025/02/26
In this episode of The Pharm So Hard Emergency Medicine Podcast, host Jimmy Pruitt, PharmD, BCPS, BCCCP, BCEMP, explores the potential of SGLT2 inhibitors in critically ill patients with guest Daniella Abi Kheir, PharmD. Traditionally viewed as diabetes medications, SGLT2 inhibitors are now gaining attention for their pleiotropic effects, including cardiovascular, renal, and anti-inflammatory benefits.
Together, Jimmy and Daniella dive into the DEFENDER trial, the first study to evaluate SGLT2 inhibitors in ICU patients with acute organ dysfunction. They break down the study design, key findings, and practical implications for managing critically ill patients. Could these drugs help prevent renal replacement therapy or improve outcomes in septic patients?
The episode also tackles potential safety concerns, including DKA and altered absorption in critically ill populations, while offering actionable insights for clinicians considering SGLT2 inhibitors in the ICU. Tune in for an evidence-based discussion packed with clinical pearls and takeaways.
★ Support this podcast ★
Episode 121. Journavix: A New Era in Non-Opioid Pain Management?
2025/02/05
In this episode of The Pharm So Hard Emergency Medicine Podcast, host Jimmy Pruitt, PharmD, BCPS, BCCCP, BCEMP, is joined by William Amarquaye, PharmD, to discuss Journavix, the first non-opioid pill approved for moderate to severe acute pain in over 20 years. They break down its mechanism as a NAV1.8 sodium channel blocker, compare it to existing analgesics, and analyze clinical trial data on its efficacy and safety. The conversation also tackles key considerations like side effects, drug interactions, and cost implications for real-world use.
★ Support this podcast ★
Episode 120. Ketamine for Benzodiazepine-Resistant Status Epilepticus – A Game-Changer?
2025/01/29
Episode 120. Ketamine for Benzodiazepine-Resistant Status Epilepticus – A Game-Changer?
In this episode of The Pharm So Hard Emergency Medicine Podcast, host Jimmy Pruitt, PharmD, BCPS, BCCCP, BCEMP dives deep into an exciting new study exploring ketamine as a rescue agent for benzodiazepine-resistant status epilepticus. Traditionally, managing refractory seizures often requires intubation, high-dose propofol, or other antiepileptics. But could ketamine provide rapid and effective seizure control in these critical moments?
Jimmy discusses key findings from the study, practical implications for the ED, and how this data could influence your choice of induction agents during intubation. Plus, he shares valuable clinical pearls and caveats when considering ketamine use in different patient populations.
00:00 Introduction
02:16 The Clinical Dilemma: Benzodiazepine-Resistant Status Epilepticus
03:39 Introducing the Study: Ketamine as a Rescue Drug
05:16 Key Findings: Rapid Seizure Termination
06:05 Safety and Dosing Insights
06:42 Clinical Implications: Ketamine in ED Practice
07:05 Caveats and Patient Populations
07:55 Conclusion
★ Support this podcast ★
Episode 119. Cephalosporins for Pyelonephritis: Insights from the COPY-ED Study
2024/12/08
In Episode 119 of The Pharm So Hard Emergency Medicine Podcast, Jimmy Pruitt, PharmD, BCPS, BCCCP, BCEMP, dives into the COPY-ED study, which explores cephalosporins as a viable option for treating outpatient pyelonephritis. Jimmy challenges the fluoroquinolone-dominant narrative, breaks down the study’s methods and results, and highlights the implications for emergency medicine pharmacists.
★ Support this podcast ★
Episode 118. Does Roc Rock and Succs Really Suck? Paralyzing Agents in RSI
2024/10/31
In this episode of The Pharm So Hard Podcast, host Jimmy Pruitt, PharmD, BCPS, BCCCP, BCEMP, and guest Rosa Malloy-Post, MD, delve into the debate over the most suitable paralyzing agent for rapid sequence intubation (RSI). They weigh the advantages and disadvantages of Succinylcholine ("Succ") and Rocuronium ("Roc") by comparing their pharmacologic properties, onset, duration, side effects, and clinical use cases. Listen for expert perspectives, practical insights, and essential factors to consider when choosing the right agent in emergency settings, and find out if "Roc truly rocks" or if "Succs really suck.
★ Support this podcast ★
Episode 117. Early Subcutaneous Basal Insulin in Mild to Moderate DKA: A Discussion with Tessa and Brian
2024/08/13
In this episode, host Jimmy L. Pruitt III, PharmD, BCPS, BCCCP, BCEMP, welcomes Tessa R. Cox, PharmD, BCCCP, and Brian W. Gilbert, PharmD, MBA, FCCM, FNCS, BCCCP, to discuss their study on the early administration of subcutaneous (SQ) basal insulin in mild to moderate diabetic ketoacidosis (DKA). The episode covers the definition and treatment of DKA, the role of insulin therapy, and the design and results of the retrospective study, which found no significant difference in hospital length of stay between early and non-early SQ basal insulin groups. The discussion includes an analysis of the study outcomes, clinical implications, and the need for further research. Tessa R. Cox and Brian W. Gilbert share their expert insights on DKA management and the relevance of the study findings to emergency medicine.
★ Support this podcast ★
Podcast reviews
Read The Pharm So Hard Emergency Medicine & Hospital Pharmacy Podcast podcast reviews
acavemancandoit 2023/11/11
Distracting sound quality
Great content, experienced clinicians, but the sound quality was so distracting that I had to stop listening. It sounds like someone is cleaning the m...
GOAT Watts 2023/01/16
Ryan
Great podcast. Amazing material with studies to support it! I’ve learned so much over listening to these. And use them as a reference in my practice. ...
Hadley Edelmayer 2022/11/18
Pharmacy Student Perspective
Absolutely love the podcast! Has definitely provided me with a lot of out of school knowledge that has been beneficial to me during my APPE year! Look...
PCSP student 2022/11/17
Keeps me up to date
Pharm So Hard is an exceptional podcast that continues to keep me updated on new and emerging topics in emergency medicine. Jimmy is also not scared t...
Rxdyer 2022/11/13
Definitely pharming hard!
Enjoying every single podcast episode!! This podcast has helped me to expand my knowledge base while commuting to/from work. I have also started recom...
PharmGirl2017 2022/05/24
Great Podcast and Great Content
Super informative, Jimmy and Oscar put a lot of work into their content and you can tell.
random ed foc 2022/05/13
Random Ed doc
Very poor sound quality on UTI episode. Had to stop listening to this one
Gerads 2021/02/20
love this podcast!
Dr Pruitt is fantastic, incredibly knowledgeable host giving away amazing pharmacy pearls to to stay up to date and keeping me sounding smart on round...
d.clay2 2020/05/18
Great
Amazing podcast. Keep up the great work Jimmy & Oscar. Content is relevant & concise just the way I like it!
Podcast sponsorship advertising
Start advertising on The Pharm So Hard Emergency Medicine & Hospital Pharmacy Podcast relevant audience podcasts
You may also like to advertise on these Podcasts

4.828116459
Huberman Lab
Scicomm Media

4.240683
To Be The Man
Podcast Heat | Cumulus Podcast Network

4.41511782000
The Ben Shapiro Show
The Daily Wire

4.2155648
TENNIS.com Podcast
TENNIS.com Podcast/Tennis Channel Podcast Network

4.510879779
The Joe Budden Podcast
The Joe Budden Network

4.611699506
The Bulwark Podcast
The Bulwark

4.711532393
Matt and Shane's Secret Podcast
Matt McCusker & Shane Gillis

4.72577183
Smosh Reads Reddit Stories
Smosh

4.975278756
Small Town Murder
James Pietragallo, Jimmie Whisman

4.71326596
Bulwark Takes
The Bulwark
